开发基于生物结合物的输送系统,用于核酸
Aniket Wahane1, Vishal Kasina1, Mounika Pathuri1
1Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269, USA.
概括
核酸药物通过调节基因表达来提供遗传疾病的潜力. 使用像GalNAc结合这样的策略,以有针对性的交付是他们临床成功的关键.
科学领域:
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 核酸通过RNAi,mRNA降解,拼接调节和翻译阻断来调节基因表达.
- 它们通过向异常基因表达来治疗遗传和罕见疾病的潜力.
- 有针对性的治疗是阻碍核酸治疗药物的临床采用的一个重大挑战.
研究的目的:
- 审查核酸药物类别及其作用机制.
- 讨论核酸药物输送中的挑战.
- 详细阐述生物结合策略的进展,以实现有针对性的交付.
主要方法:
- 审查关于核酸治疗的现有文献.
- 分析化学修饰和生物结合的交付策略.
- 对器官和细胞特异性向的连接体发育的检查.
主要成果:
- N-乙银胺 (GalNAc) 结合能够向肝脏,从而导致FDA批准的核酸药物.
- 目前正在探索各种生物结合策略,以加强器官和细胞向.
- 为了改善核酸药物输送,正在开发各种配体.
结论:
- 生物结合策略对于克服核酸药物输送挑战至关重要.
- 有针对性的治疗增强了核酸药物的治疗潜力.
- 连接体开发的持续进展有望为核酸疗法提供更广泛的临床应用.
相关概念视频
Nucleic acids
199.2K
Nucleic acids are the most important macromolecules for the continuity of life. They carry the cell's genetic blueprint and carry instructions for its functioning.
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
199.2K
Drug Delivery: Overview
1.2K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.2K
Drug Delivery Systems: Different Types
322
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
322
Modified-Release Drug Delivery Systems: Bioavailability
139
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
139
Modified-Release Drug Delivery Systems: Site-Targeted
141
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
141
Site-Targeted Drug Delivery Systems: Polymeric Carriers
127
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
127


